Latanoprost E Timololo Aurobindo Italia

Timolol maleate and Latanoprost, the active ingredients in Latanoprost E Timololo Aurobindo Italia, are a beta‑blocker and a prostaglandin analog presented as eye drops for ocular use. They lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension.

GNH USA supplies Latanoprost E Timololo Aurobindo Italia as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Latanoprost E Timololo combines a beta‑blocker and a prostaglandin analog to manage intra‑ocular pressure in glaucoma‑related conditions. - Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. - Ocular hypertension: lowers pressure to prevent conversion to glaucoma. - Post‑operative intra‑ocular pressure control: helps maintain target pressure after ocular surgery.

The following adverse reactions have been reported with the combination eye drops.

Common Side Effects: - Eye irritation: transient burning or stinging after instillation. - Blurred vision: temporary visual disturbance. - Redness of the eye: conjunctival hyperemia. - Itching or discomfort: mild pruritus around the ocular surface. - Dry eye sensation: reduced tear film stability. - Foreign body sensation: feeling of something in the eye.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, rash, or anaphylaxis. - Worsening of glaucoma: unexpected rise in intra‑ocular pressure. - Chest pain or palpitations: systemic β‑blocker effects. - Bradycardia: markedly reduced heart rate. - Severe eye inflammation: uveitis or keratitis. - Systemic hypoglycaemia: especially in diabetic patients using β‑blockers.

Before using Latanoprost E Timololo, consider the following safety measures. - Pregnancy: consult a physician, as safety data are limited. - Breastfeeding: weigh potential risks versus benefits. - Cardiovascular disease: monitor heart rate and blood pressure. - Respiratory disease: avoid in patients with asthma or COPD due to β‑blockade. - Drug interactions: review concomitant medications for additive β‑blocker effects. - Store at room temperature: keep the bottle tightly closed, protect from light and moisture.

Latanoprost E Timololo may interact with other medicines; categorize the risk level.

Major Interactions (Avoid): - Other ocular β‑blockers: may cause excessive systemic β‑blockade. - Systemic β‑agonists (e.g., albuterol): can reduce bronchodilator efficacy.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: may enhance blood‑pressure lowering effects. - Calcium channel blockers: possible additive cardiac effects. - Other prostaglandin analogs: increased risk of ocular hyperemia. - Non‑steroidal anti‑inflammatory eye drops: may alter prostaglandin metabolism.